Depressive disorders, General Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder Mental and Behavioural Disorders Depressive disorders, General Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosis of a psychiatric disorder being explored 2. Aged 18 years or more 3. Reasonable command of Finnish language 4. Access to the internet 5. Provided informed consent 6. Referral to the HUS-iCBT by the patient’s treating physician
Exclusion criteria
Exclusion criteria: 1. Reported or observed suicidal intentions 2. Current alcohol misuse as judged by referring physician 3. Known diagnosis of schizophrenia or other psychotic disorder, bipolar disorder or serious personality disorder 4. Neurologic or neuropsychiatric disorder that adversely affects the patient’s cognitive performance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes are a disorder-specific symptom measure scale. For each specific disorder, we measure one or two pertinent symptom scales as primary measures: Beck’s Depression Inventory (BDI) for Depressive Disorders, Panic Disorder Severity Scale (PDSS-SR) for Panic disorder, Generalized Anxiety Disorder 7-item Scale (GAD-7) and Penn State Worry Questionnaire (PSWQ) for Generalized Anxiety Disorder, Obsessive-Compulsive Inventory, short version (OCI-R) for Obsessive-Compulsive Disorder, Social Phobia Inventory, Finnish version (SPIN-FIN) for Social Anxiety Disorder and Sleep Disorders, and Eating Disorder Examination Questionnaire (EDE-Q), the Eating Disorder Examination-Self-Report Questionnaire Version (EDE-Q) for Bulimia Nervosa. The scales are applied at baseline, mid-treatment and endpoint with the exception of GAD-7 which is applied as each session. All measures are filled in by patients online. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Overall Anxiety Severity and Impairment Scale (OASIS) assessed at baseline and mid-treatment 2. Health-Related Quality of Life scale 15D at baseline, end-point and three months follow-up | — |
Countries
Finland